Skip to main content
logo
Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
105.70
+0.09 (0.09%)
At close: Jul 31, 2026, 4:00 PM EDT
106.04
+0.34 (0.32%)
After-hours: Jul 31, 2026, 7:52 PM EDT

Abbott Laboratories Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
5,4256,52413,4025,7236,9337,071
Depreciation & Amortization
3,4463,1163,2183,2433,2673,538
Stock-Based Compensation
718664673644685640
Other Adjustments
-6548212621555
Change in Receivables
-408-652-691-356-68-383
Changes in Inventories
-274195-58-232-1,413-456
Changes in Accounts Payable
-954356-7604201,288
Changes in Income Taxes Payable
--5-8,028-585-383-908
Changes in Other Operating Activities
820-1,295-796-542-75-312
Operating Cash Flow
9,9059,5668,5587,2619,58110,533
Operating Cash Flow Growth
9.61%11.78%17.86%-24.21%-9.04%33.31%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,081-2,171-2,207-2,202-1,777-1,885
Purchases of Investments
--167-169-159-185-173
Proceeds from Sale of Investments
-1403284315277
Cash Acquisitions
-20,037-105--877--187
Proceeds from Business Divestments
--14048134
Other Investing Activities
58189222226
Investing Cash Flow
-22,367-2,422-2,338-3,133-1,740-2,008

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
19,8295223274
Long-Term Debt Repaid
-3,323-1,504-660-2,498-753-48
Net Long-Term Debt Issued (Repaid)
16,506-1,499-437-2,496-746-44
Issuance of Common Stock
193396264167167255
Repurchase of Common Stock
-1,832-893-1,295-1,227-3,795-2,299
Net Common Stock Issued (Repurchased)
-1,639-497-1,031-1,060-3,628-2,044
Common Dividends Paid
-4,261-4,116-3,836-3,556-3,309-3,202
Other Financing Activities
32-197-1002147-204
Financing Cash Flow
10,638-6,309-5,404-7,091-7,636-5,494

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2371-96-23-122-70
Net Cash Flow
-1,847906720-2,986832,961

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,8247,3956,3515,0597,8048,648
Free Cash Flow Growth
15.48%16.44%25.54%-35.17%-9.76%51.08%
FCF Margin
16.80%16.68%15.14%12.61%17.88%20.08%
Free Cash Flow Per Share
4.484.233.632.894.424.83
Levered Free Cash Flow
23,8425,8195,4502,1496,2268,292
Unlevered Free Cash Flow
7,2177,0005,5284,4857,0198,520
SEC Filings: 10-K · 10-Q